| [1] |
Anothaisintawee T, Teerawattananon Y, Wiratkapun C, et al. Risk prediction models of breast cancer: a systematic review of model performances[J]. Breast Cancer Res Treat,2012,133 (1):1-10.
|
| [2] |
Zhu W, Qin W, Hewett JE, et al. Quantitative evaluation of DNA hypermethylation in malignant and benign breast tissue and fl uids[J]. Int J Cancer,2010, 126(2):474-82.
|
| [3] |
Cho KW, Kwon HJ, Shin JO, et al. Retinoic acid signaling and the initiation of mammary gland development[J]. Dev Biol,2012, 365 (1) :259-66.
|
| [4] |
Salazar MD, Ratnam M, Patki M, et al. During hormone depletion or tamoxifen treatment of breast cancer cells the estrogen receptor apoprotein supports cell cycling through the retinoic acid receptor alpha1 apoprotein[J]. Breast Cancer Res,2011,13(1):R18.
|
| [5] |
Herman JG, Graff JR, Myöhänen S, et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands[J]. Proc Natl Acad Sci U S A,1996,93 (18): 9821-6.
|
| [6] |
Paulin R, Grigg GW, Davey MW, et al. Urea improves efficiency of bisulphate-mediated sequencing of 5’-methylcytosine in genomic DNA[J]. Nucleic Acids Res,1998, 26 (21): 5009-10.
|
| [7] |
Zlobec I, Bihl M, Foerster A, et al. Comprehensive analysis of CpG island methylator phenotype (CIMP)-high, -low, and -negative colorectal cancers based on protein marker expression and molecular features[J]. J Pathol,2011, 225(3):336-43.
|
| [8] |
Soong R, Iacopetta BJ, Harvey JM, et al. Detection of p53 gene mutation by rapid PCR-SSCP and its association with poor survival in breast cancer[J]. Int J Cancer,1997, 74 (6): 642-7.
|
| [9] |
Lee X, Si SP, Tsou HC, et al. Cellular aging and transformation suppression: a role for retinoic acid receptor beta 2[J]. Exp Cell Res, 1995, 218 (1):296-304.
|
| [10] |
Sun J, Xu X, Liu J, et al. Epigenetic regulation of retinoic acid receptorβ2 gene in the initiation of breast cancer[J]. Med Oncol, 20 11, 28(4):1311-8.
|
| [11] |
Lewis CM, Cler LR, Bu DW, et al. Promoter hypermethylation in benign breast epithelium in relation to predicted breast cancer risk[J]. Clin Cancer Res, 2005, 11(1):166-72.
|
| [12] |
Yang Q, Mori I, Shan L, et al. Biallelic inactivattion of retinoic acid receptor beta2 gene by epigenetic change in breast cancer[J]. Am J Pathol, 2001,158(1):299-303.
|
| [13] |
Yan PS, Perry MR, Laux DE, et al. CpG island arrays: an application toward deciphering epigenetic signatures of breast cancer[J]. Clin Cancer Res, 2000, 6(4): 1432-8.
|
| [14] |
Nass SJ, Herman JG, Gabrielson E, et al. Aberrant methylation of the estrogen receptor and E-cadherin 5’CpG islands increases with malignant progression in human breast cancer[J]. Cancer Res, 2000 ,60 (16): 4346-8.
|
| [15] |
Toyota M, Ahuja N, Ohe-Toyota M, et al. CpG island methylator phenotype in colorectal cancer[J]. Proc Natl Acad Sci U S A, 19 99, 96 (15): 8681-6.
|
| [16] |
Hawkins N, Norrie M, Cheong K, et al. CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability[J]. Gastroenterology, 2002, 122 (5): 1376-87.
|
| [17] |
van Rijnsoever M, Grieu F, Elsaleh H, et al. Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands[J]. Gut, 2002, 51 (6):797-802.
|
| [18] |
Fackler MJ, McVeigh M, Evron E, et al. DNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma[J]. Int J Cancer, 2003, 107(6): 970-5.
|
| [19] |
Yang X, Yan L, Davidson NE. DNA methylation in breast cancer[J]. Endocr Relat Cancer, 2001, 8 (2): 115-27.
|
| [20] |
Mehrotra J, Ganpat MM, Kanaan Y, et al. Estrogen receptor/ progesterone receptor-negative breast cancers of young African- American women have a higher frequency of methylation of multiple genes than those of Caucasian women[J]. Clin Cancer Res, 2004, 10 (6): 2052-7.
|
| [21] |
Widschwendter M, Siegmund KD, Müller HM, et al. Association of breast cancer DNA methylation profiles with hormone receptor status and response to tamoxifen[J]. Cancer Res,2004,64 (11):3807-13.
|
下载:
